Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

SHA:600521 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,342	1,365	1,876	2,212	1,504
Short-Term Investments	-	-	-	-	2
Trading Asset Securities	93.04	143.07	1.01	-	-
Cash & Short-Term Investments	1,435	1,508	1,877	2,212	1,506
Cash Growth	-4.82%	-19.66%	-15.13%	46.83%	65.40%
Accounts Receivable	2,557	2,831	1,906	1,757	1,404
Other Receivables	28.4	47.43	40.85	39.85	20.56
Receivables	2,585	2,879	1,947	1,797	1,424
Inventory	3,432	3,375	2,739	2,368	2,217
Prepaid Expenses	4.25	-	-	0	0.02
Other Current Assets	164.61	145.35	250.18	145.84	119.07
Total Current Assets	7,622	7,907	6,813	6,523	5,267
Property, Plant & Equipment	7,994	7,307	5,961	4,366	3,803
Long-Term Investments	785.25	863.17	1,027	641.78	495.43
Goodwill	64.45	70.9	70.9	70.9	70.9
Other Intangible Assets	1,113	1,072	970.6	806.93	647.94
Long-Term Deferred Tax Assets	171.99	183.9	110.15	175.73	123.63
Long-Term Deferred Charges	843.04	737.88	508.28	387.7	310.8
Other Long-Term Assets	6.45	9.46	7.87	18.51	10.91
Total Assets	18,600	18,152	15,468	12,991	10,729
Accounts Payable	1,387	1,203	881.79	894.34	577.04
Accrued Expenses	735.43	898.42	791.6	471.8	270.66
Short-Term Debt	1,583	1,397	1,314	1,005	1,417
Current Portion of Long-Term Debt	1,191	630.76	630.99	123.83	710.97
Current Portion of Leases	16.82	16.72	13.82	-	-
Current Income Taxes Payable	91.14	264.11	187.9	165.71	38.06
Current Unearned Revenue	33.51	67.7	66.71	40.09	-
Other Current Liabilities	407.71	321.64	348.93	190.42	342.89
Total Current Liabilities	5,445	4,799	4,236	2,891	3,357
Long-Term Debt	4,022	4,678	3,498	2,921	1,179
Long-Term Leases	44.93	59.14	66.41	-	-
Long-Term Unearned Revenue	665.44	532.09	448.44	299.36	292.2
Long-Term Deferred Tax Liabilities	-	-	-	-	0.08
Other Long-Term Liabilities	171.02	338	443.51	155.3	122.14
Total Liabilities	10,349	10,406	8,692	6,267	4,951
Common Stock	1,483	1,483	1,492	1,455	1,322
Additional Paid-In Capital	1,296	1,322	1,381	1,040	1,162
Retained Earnings	5,470	4,992	3,971	3,774	3,109
Treasury Stock	-416.91	-484.25	-521.84	-	-
Comprehensive Income & Other	244.43	233.98	236.54	243.73	16.39
Total Common Equity	8,077	7,547	6,559	6,513	5,610
Minority Interest	174.26	199.07	217.48	211.14	169.11
Shareholders' Equity	8,251	7,746	6,776	6,724	5,779
Total Liabilities & Equity	18,600	18,152	15,468	12,991	10,729
Total Debt	6,858	6,782	5,523	4,050	3,308
Net Cash (Debt)	-5,422	-5,273	-3,646	-1,838	-1,801
Net Cash Per Share	-3.74	-3.61	-2.54	-1.26	-1.30
Filing Date Shares Outstanding	1,468	1,473	1,484	1,455	1,455
Total Common Shares Outstanding	1,468	1,473	1,484	1,455	1,455
Working Capital	2,176	3,109	2,577	3,632	1,910
Book Value Per Share	5.34	4.96	4.26	4.31	3.86
Tangible Book Value	6,899	6,403	5,517	5,635	4,891
Tangible Book Value Per Share	4.54	4.18	3.56	3.71	3.36
Buildings	3,757	2,839	2,151	-	1,898
Machinery	175.56	152.08	3,827	-	2,851
Construction In Progress	2,317	2,803	2,502	-	929.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.